Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: Lessons from APEX-AMI

European Heart Journal

Volumn 28, Issue 23, 2007, Pages 2850-2857

  Tjandrawidjaja, Michael C ^a   Fu, Yuling ^a   Al Khalidi, Hussein ^b   Todaro, Thomas G ^b   Adams, Peter ^c   Van De Werf, Frans ^d   Granger, Christopher B ^e   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^c ALEXION PHARMACEUTICALS   (United States)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Clinical trials; ECG; Myocardial infarction

Indexed keywords

PEXELIZUMAB;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

AGED; ANTIBODIES, MONOCLONAL; CARDIOVASCULAR AGENTS; ELECTROCARDIOGRAPHY; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MYOCARDIAL INFARCTION; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 36849083033     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm453     Document Type: Article

References (13)

1. Holmvang L, Hasbak P, Clemmensen P, Wagner GS, Grande P. Differences between local investigator and core laboratory interpretation of the admission electrocardiogram in patients with unstable angina pectoris or non-Q-wave myocardial infarction (a Thrombin Inhibition in Myocardial Ischemia [TRIM] substudy). Am J Cardiol 1998;82:54-60.
2. Goodman SG, Fu Y, Langer A, Barr A, Tan M, Wagner GS, Barbagelata A, Sgarbossa EB, Birnbaum Y, Granger CB, Califf RM, Van de Werf F, Topol EJ, Armstrong PW, for the GUSTO-IIB Investigators. The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG core laboratory experience. Am Heart J 2006;152:277- 284.
3. The APEX-AMI Investigators. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 2007;297:43-51.
4. Hindman NB, Schocken DD, Widmann M, Anderson WD, White RD, Leggett S, Ideker RE, Hinohara T, Selvester RH, Wagner GS. Evaluation of a QRS scoring system for estimating myocardial infarct size. Am J Cardiol 1985;55:1485-1490.
5. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM, for the GUSTO I- investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. Circulation 1995;91:1659-1668.
6. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS, for the DANAMI-2 investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733- 742.
7. Armstrong PW, WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006;27:1530-1538.
8. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006;367:569-578.
9. Bates ER. Revisiting reperfusion therapy in inferior myocardial infarction. J Am Coll Cardiol 1997;30:334-342.
10. Berger PB, Ryan TJ. Inferior myocardial infarction: high-risk subgroups. Circulation 1990;81:401-411.
11. Hlatky MA, Califf RM, Lee KL, Pryor DB, Wagner GS, Rosati RA. Prognostic significance of precordial ST segment depression during inferior acute myocardial infarction. Am J Cardiol 1985;55:325-329.
12. Birnbaum Y, Wagner GS, Barbash GI, Gates K, Criger DA, Sclarovsky S, Siegel RJ, Granger CB, Reiner JS, Ross AM. Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarction. Am J Cardiol 1999;83:143-148.
13. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502- 1513.